It's no secret most women struggle with putting on extra, unwanted pounds as they approach "the change". This issue leads women desperate to figure out how to lose weight during perimenopause.
The Centre for Pharmacy Post-Graduate Education (CPPE) has launched Menopause - an introduction for pharmacy professionals e-learning programme.
The new Menopause: an introduction for pharmacy professionals e-learning programme aims to support pharmacist's to increase their knowledge and awareness of
menopause and perimenopause, helping them to have initial conversations with those who need support.
The programme teaches how to equip people experiencing menopausal symptoms with evidence-based information that allows them to make decisions about their own
health management.
This e-learning programme considers a range of topics, including the signs and symptoms associated with menopause and perimenopause, how a diagnosis is made
and the national context supporting a growing role for pharmacy professionals in menopause care.
It also discusses the benefits and risks of treatment options available, the common misconceptions that people may have about menopause and how to apply the
evidence base to practice in order to help support decision making.
Veoza, a non-hormonal treatment for menopause, has been made available on the high street for the first time in the UK.
British pharmacy chain Superdrug on Thursday (1st February) announced the launch of the newly approved menopause medication, expanding its comprehensive
portfolio of products and services to support menopausal women.
Veoza is a prescription medication that is used to manage vasomotor symptoms, specifically hot flushes and night sweats, which affect up to 80 per cent of women
during menopause, as estimated by experts.
It is recommended for women who prefer not to or are unable to take hormone replacement.
Perimenopausal, menopausal and postmenopausal women, aged 45-65 who are not on Hormone Replacement Therapy (HRT) or hormonal contraception, and are suffering
from moderate to severe vasomotor symptoms, are eligible to take the medication, the retailer said in a release.
Britain's health regulator is poised to announce that hormone replacement therapy (HRT) will be made available over the counter for the first time, the Daily Telegraph has revealed.
The newspaper first reported on Tuesday (February 1) that watchdogs were set to propose a reclassification of the medication so women are able to access it in a pharmacy without a prescription.
Every year, some 1.5 million women experience difficult menopausal symptoms, such as hot flushes, night sweats, sleep disturbance and a variety of emotional problems.
But only a tenth of them are prescribed HRT, following a consultation with a GP or specialist.
According to the newspaper, the latest proposal aims to improve convenience so that women are able to access HRT more easily, without needing a GP appointment.
